Life Science Intelligence

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.
Find me on:

Recent Posts

The Weekly Medtech Pro Report: Inferior Vena Cava Filter Market, Cataract Surgeries, & Startup Spotlight

Posted by Life Science Intelligence on Sep 2, 2021 11:05:47 AM

Life Science Intelligence’s Weekly Medtech Pro Review provides a preview of select market data and startups covered in the full Medtech Pro Platform, which is a comprehensive market intelligence solution for medtech executives. As a preview of the types of content found on Medtech Pro, the Weekly Medtech Pro Review will cover select market data, procedure volumes, and startups.

Read More

Medtech Startups: Trice Medical, Nutromics, Venstra Medical, & more

Posted by Life Science Intelligence on Aug 31, 2021 11:00:22 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals approximately $110M in funding was raised across 9 deals, in addition to other undisclosed deals that were announced. This represents a slight uptick in total weekly fundraising after 3 weeks of declining volumes. The majority of the fundraising for the week was attributable to startups in the digital health sector.

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Medtech Startups: LumiraDx, Optellum, Ultromics, & more

Posted by Life Science Intelligence on Aug 25, 2021 7:16:41 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This past week continues the decline in medtech startup fundraising deals, with approximately $85.5M in funding raised across 4 deals. The total weekly fundraising amount for medtech startups has continued to fall off from the $446M high seen three weeks ago.

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

The Weekly Medtech Pro Report: Discectomy Procedures, the Endoscopic ENT market, and Startup Spotlight

Posted by Life Science Intelligence on Aug 19, 2021 9:49:49 AM

Life Science Intelligence’s Weekly Medtech Pro Review provides a preview of select market data and startups covered in the full Medtech Pro Platform, which is a comprehensive market intelligence solution for medtech executives. As a preview of the types of content found on Medtech Pro, the Weekly Medtech Pro Review will cover select market data, procedure volumes, and startups.

Read More

Medtech Startups: Neuromersiv, Mahana Therapeutics, Zilia, & more

Posted by Life Science Intelligence on Aug 18, 2021 8:40:39 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

The lull in medtech startup fundraising transactions continues from last week, with approximately $93.2M in funding raised across 5 deals. Total fundraising continues to decline from the $446M high seen two weeks ago.

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Neurostimulation Procedures, the Cryoablation market, and Startup Spotlight

Posted by Life Science Intelligence on Aug 12, 2021 6:00:00 AM

Life Science Intelligence is debuting new weekly content series – the Weekly Medtech Pro Report. The Weekly Medtech Pro Review provides a preview of select market data and startups covered in the full Medtech Pro Platform, which is a comprehensive market intelligence solution for medtech executives. As a preview of the types of content found on Medtech Pro, the Weekly Medtech Pro Review will cover select market data, procedure volumes, and startups.

Read More

Case Study: Pre-Revenue Life Sciences Company Raises $60M via Reg A+

Posted by Life Science Intelligence on Aug 11, 2021 10:53:04 AM

Regulation A+ allows companies to raise up to $75M per year from both accredited and non-accredited investors. A common question founders have is whether it is really possible for a life sciences company to do raises of that size via Reg A+, especially if they’re pre-revenue, even pre-clinical. And the answer is yes.

Read More

Medtech Startups: Eyevensys, Respira Labs, SleepCogni, & more

Posted by Life Science Intelligence on Aug 10, 2021 12:07:23 PM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals approximately $124.5M in funding was raised across 4 deals, in addition to other undisclosed deals that were announced. This represents a significant decrease in weekly medtech fundraising when compared to last week’s $446.1M. Here are some of the top deals tracked:

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Medtech Startups: Neuro42, OneraHealth, Sharper Sense & more

Posted by Life Science Intelligence on Aug 4, 2021 6:59:22 AM

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.

This week in medtech deals approximately $446M in funding was raised across 12 deals, in addition to several other undisclosed deals that were announced. This is a sizable increase in funds raised when compared to last week’s $111M. Here are some of the top deals tracked:

Read More

Topics: Startup, Strategics, Medtech, Medtech Innovation Weekly Update

Why Now Is the Time to Raise Capital

Posted by Life Science Intelligence on Jul 28, 2021 7:06:08 AM

If you’ve been paying any attention to the news, you know that the pandemic has brought about a sea change in the role of retail investors. Last year saw Reddit users taking on institutional investors. This week, Robinhood is defying convention and reserving 35% of its IPO for retail investors through its app. Last week, retail dip buyers drove the rally against the Monday plunge in reaction to concerns about the corona delta variant.

But here’s the macro story underneath that’s not making the big headlines:  investors have cash and are eager to deploy it. According to Bloomberg, there’s $17 Trillion Burning a Hole in Pockets

Read More